You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API sapropterin dihydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing sapropterin dihydrochloride

Company Ingredient NDC Excipient
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045 ASCORBIC ACID
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045 CROSPOVIDONE
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045 MANNITOL
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045 RIBOFLAVIN
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for sapropterin dihydrochloride

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

sapropterin dihydrochloride drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-047
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-096
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-097
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-162
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ASCORBIC ACID

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

sapropterin dihydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-045
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-047
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-097
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-162
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-477
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MANNITOL

Excipient focus: POTASSIUM CITRATE

Excipient focus: RIBOFLAVIN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STEARYL FUMARATE

sapropterin dihydrochloride drug variants not containing SODIUM STEARYL FUMARATE

Company Ingredient NDC
Camber Pharmaceuticals Inc sapropterin dihydrochloride 31722-047
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-097
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-162
Dr Reddys Laboratories Inc sapropterin dihydrochloride 43598-477
Par Pharmaceutical Inc sapropterin dihydrochloride 49884-873
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SUCRALOSE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group